Interleukin-15, as interferon-gamma, induces the killing of Leishmania infantum in phorbol-myristate-acetate-activated macrophages increasing interleukin-12

Scandinavian Journal of Immunology

Volumn 60, Issue 6, 2004, Pages 609-614

  D'Agostino, P ^a   Milano, S ^a   Arcoleo, F ^b   Di Bella, G ^b   La Rosa, M ^b   Ferlazzo, V ^a   Caruso, R ^b   Chifari, N ^a   Vitale, G ^a   Mansueto, S ^a   Cillari, E ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIBODY RESPONSE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE ACTIVATION; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; TETRADECANOYLPHORBOL ACETATE;

EID: 10844282774     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01522.x     Document Type: Article

References (31)

1. Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today 1994;7:264-6.
2. + T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 1996;17:13-6.
3. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-77.
4. Liew FY, Wei XQ, Proudfoot L. Cytokines and nitric oxide as effector molecules against parasitic infections. Philos Trans R Soc Lond B Biol Sci 1997;352:1311-5.
5. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD. Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 1985;76:2066-9.
6. Sacks DL, Lai SL, Shrivastava SN, Blackwell J, Neva FA. An analysis of T cell responsiveness in Indian kala-azar. J Immunol 1987;138:908-13.
7. Cillari E, Milano S, Dieli M et al. Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patient with visceral leishmaniasis. J Immunol 1991;146:1026-30.
8. Cillari E, Liew FY, Lo Campo P, Milano S, Mansueto S, Salerno A. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily. J Immunol 1988;140:2721-6.
9. Milano S, Di Bella G, D'Agostino P et al. IL-15 in human visceral leishmaniasis caused by Leishmania infantum. Clin Exp Immunol 2002;127:360-5.
10. Cillari E, Dieli M, Maltese E, Milano S, Salerno A, Liew FY. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-γ. J Immunol 1989;143:2001-5.
11. Ghalib HG, Piuvezam MR, Skeiky YAW et al. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993;92:324-9.
12. Liew FY, Li Y, Millott S. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 1990;71:556-9.
13. Vouldoukis I, Becherel PA, Riveros-Moreno V et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997;27:860-5.
14. Carson WE, Ross ME, Baiocchi RA et al. Endogenous production of interleukin-15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995;96:2578-82.
15. Ghalib HW, Wittle JA, Kubin M et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 1995;154:4623-9.
16. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol 1998;28:669-80.
17. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
18. Nabors GS. Modulating ongoing Th2-cell responses in experimental leishmaniasis. Parasitol Today 1997;13:76-9.
19. Weidmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49.
20. Lauwerys BR, Garot N, Renauld JC, Houssian FA. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol 2000;165:1847-53.
21. Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL. IL-15, an immunomodulator of T cell responses in inttacellular infection. J Immunol 1997;158:800-6.
22. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 2002;99:1273-81.
23. Chehimi J, Marshall JD, Salvucci O et al. IL-15 enhances immune functions during HIV infection. J Immunol 1997;158:5978-87.
24. Ferrari FA, Maccario R, Marconi M et al. Reliability of alpha-naphthyl-acetate esterase staining of blood smears for the enumeration of circulating human T lymphocytes. Clin Exp Immunol 1980;41:358-62.
25. Cillari E, Arcoleo F, Dieli M et al. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro. Infect Immun 1994;62:2649-52.
26. McGahon AJ, Martin SJ, Bissonnette RP et al. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol 1995;46:153-85.
27. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 2001;22:556-60.
28. Schindler H, Lutz MB, Rollinghoff M, Bogdan C. The production of IFN-gamma by IL-I2/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 2001;166:3075-82.
29. Jankovic D, Liu Z, Cause WC. Th1 and Th2 cell commitment during infections disease: asymmetry in divergent pathways. Trends Immunol 2001;22:450-7.
30. Liew FY. T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol 2002;2:55-60.
31. Munger W, Dejoy SQ, Jeyaseelan R Sr et al. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol 1995;165:289-93.